The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Small-Molecule Inhibitors of Ser/Thr Protein Phosphatases: Specificity, Use and Common Forms of Abuse
Open accessAbstract
Natural product extracts have proven to be a rich source of small molecules that potently inhibit the catalytic activity of certain PPP-family ser/thr protein phosphatases. To date, the list of inhibitors includes okadaic acid (produced by marine dinoflagelates, Prorocentrum sp. and Dinophysis sp.), calyculin A, dragmacidins (isolated from marine sponges), microcystins, nodularins (cyanobacteria, Microcystis sp. and Nodularia sp.), tautomycin, tautomycetin, cytostatins, phospholine, leustroducsins, phoslactomycins, fostriecin (soil bacteria, Streptomyces sp.), and cantharidin (blister beetles, approx 1500 species). Many of these compounds share structural similarities, and several have become readily available for research purposes. Here we will review the specificity of available inhibitors and present methods for their use in studying sensitive phosphatases. Common mistakes in the employment of these compounds will also be addressed briefly, notably the widespread misconception that they only inhibit the activity of PP1 and PP2A. Inhibitors of PP2B (calcineurin) will only be mentioned in passing, except to state that, in our hands, cypermethrin, deltamethrin, and fenvalerate, which are sold as potent inhibitors of PP2B, do not inhibit the catalytic activity of PP2B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bialojan, C., & Takai, A. (1988) · Biochemical Journal · doi:10.1042/bj2560283 · Cited by 1,691
Favre, B., Turowski, P., & Hemmings, B. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13856 · Cited by 300
Regulators of Serine / Threonine Protein Phosphatases at the Dawn of a Clinical Era?
Honkanen, R., & Golden, T. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023368836 · Cited by 258
Self-citationFostriecin: Chemistry and Biology
Lewy, D. S., Gauss, C.-M., Soenen, D. R., et al. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023368809 · Cited by 142
Protein Phosphatase Inhibition: Structure Based Design. Towards New Therapeutic Agents
Sakoff, J. A., & McCluskey, A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452686 · Cited by 50
Ichinose, M., Endo, S., Critz, S. D., Shenolikar, S., & Byrne, J. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)91806-r · Cited by 22
Cited by
Partial inhibition of Cdk1 in G2phase overrides the SAC and decouples mitotic events
McCloy, R. A., Rogers, S., Caldon, C. E., Lorca, T., Castro, A., & Burgess, A. (2014) · Cell Cycle · doi:10.4161/cc.28401 · Cited by 853
Inactivation of specific β cell transcription factors in type 2 diabetes
Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65390 · Cited by 520
Protein phosphatase 2A dysfunction in Alzheimer’s disease
Sontag, J.-M., & Sontag, E. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00016 · Cited by 304
Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A
Wong, P.-M., Feng, Y., Wang, J., Shi, R., & Jiang, X. (2015) · Nature Communications · doi:10.1038/ncomms9048 · Cited by 239
Martina, J. A., & Puertollano, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003471 · Cited by 177
Metadata
- Authors
- Swingle, M., Ni, L., & Honkanen, R. E.
- Venue
- Protein Phosphatase Protocols
- Publisher
- Humana Press
- Published
- 2007-01-02
- Volume
- 365
- Pages
- 23-38
- OpenAlex
- W1602148084
- Cited by
- 290
- References
- 6
- FWCI
- 14.27
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Small-Molecule Inhibitors of Ser/Thr Protein Phosphatases: Specificity, Use and Common Forms of Abuse. https://app.cochat.ai/papers/10.1385/1-59745-267-x:23
- The paper
- Swingle, M., Ni, L., & Honkanen, R. E. (2007). Small-Molecule Inhibitors of Ser/Thr Protein Phosphatases: Specificity, Use and Common Forms of Abuse. Protein Phosphatase Protocols. https://doi.org/10.1385/1-59745-267-x%3A23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.